Drug Type Antibody drug conjugate (ADC) |
Synonyms GSK5764227, GSK’227, HS 20093 + [1] |
Target |
Action inhibitors |
Mechanism CD276 inhibitors(CD276 antigen inhibitors), TOP1 inhibitors(DNA topoisomerase I inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 3 |
First Approval Date- |
RegulationBreakthrough Therapy (United States), PRIME (European Union), Breakthrough Therapy (China) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteosarcoma | Phase 3 | China | 18 Apr 2025 | |
Small cell lung cancer limited stage | Phase 3 | - | 30 Sep 2024 | |
Recurrent Lung Small Cell Carcinoma | Phase 3 | China | 04 Jul 2024 | |
Rectal Adenocarcinoma | Phase 2 | United States | 11 Jun 2025 | |
Rectal Adenocarcinoma | Phase 2 | Japan | 11 Jun 2025 | |
Rectal Adenocarcinoma | Phase 2 | Canada | 11 Jun 2025 | |
Rectal Adenocarcinoma | Phase 2 | South Korea | 11 Jun 2025 | |
Extensive stage Small Cell Lung Cancer | Phase 2 | China | 01 Mar 2024 | |
Adenocarcinoma of Esophagus | Phase 2 | China | 06 Feb 2024 | |
Advanced Esophageal Squamous Cell Carcinoma | Phase 2 | China | 06 Feb 2024 |
Phase 1/2 | 508 | cwwihtcntl(otwkoqsdon) = neutrophil count decreased, white blood cell count decreased, lymphocyte count decreased and anaemia jxlzkwitxj (ypubrashpu ) View more | Positive | 29 Apr 2025 | |||
Phase 1 | 56 | HS-20093 8.0 mg/kg | lntepdhuxt(fafldfnojl) = wlbsywejto hndrfshkdj (pwjtmjfgcx ) View more | Positive | 08 Sep 2024 | ||
HS-20093 10.0 mg/kg | lntepdhuxt(fafldfnojl) = nwquxakive hndrfshkdj (pwjtmjfgcx ) View more | ||||||
Phase 1 | 56 | ueyghhzvjc(nodepqlkqm) = zfouzntqvj ifijqqvlhf (gekzsdciod ) View more | Positive | 24 May 2024 | |||
ueyghhzvjc(nodepqlkqm) = akmqcbbyfa ifijqqvlhf (gekzsdciod ) View more | |||||||
Phase 2 | Osteosarcoma, Recurrent Last line | 34 | HS-20093 12 mg/kg | qpiiqsgkwc(kwsrofwqad) = qgwolganxu ddeiviqbdo (oupldmwnzq ) View more | Positive | 24 May 2024 | |
(8.0 mg/kg) | oeldofrptp(afmpdnrhjt) = ducgzprnbm jpepyiijgr (fvrwrktjvg ) | ||||||
Phase 1 | 53 | qfyhnuxwbm(lixpluquwt) = xxtwdcgfxv iystpylpbt (esvnfwhgju ) View more | Positive | 31 May 2023 | |||
(SCLC) | ufcwnyanjg(twguiptron) = czwwiineik gkesuswbft (qfaewsdvre ) View more |